Every finding on record at Happy Hospice Inc

Upon patient record review, 1 of 10 (Patient #1) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient 01: The medication profile includes Latanoprost 0.005% opthalmic solution instill 1 drop daily at bedtime, the profile does not indicate which eye/s to administer to. The medication profile includes Restasis 0.05%, 1 drop twice a day, the profile does not indicate which eye/s to administer to. (Corrected on site.)

Upon patient record review, 1 of 10 (Patient #03) did not have evidence in the patient record that the comprehensive assessment includes a bereavement component which includes the needs of the patient's family and other individuals focusing on the social, spiritual, and cultural factors that may impact their ability to cope with the patient's death. Information gathered from the initial bereavement assessment is incorporated into the plan of care and is considered in the bereavement plan of care. Patient 03: The patient was admitted on 1/27/22, the record does not include an initial bereavement assessment.

Upon patient record review, 1 of 10 (Patient #1) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient 01: The medication orders on 7/7/23 for Latanoprost 0.005% opthalmic solution instill 1 drop daily at bedtime, does not indicate which eye/s to administer to. The medication order on 7/7/23 for Restasis 0.05%, 1 drop twice a day, does not indicate which eye/s to administer to. (Order correction entered on site.)